Last reviewed · How we verify
NCT06133933
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
trial testing Pain Threshold using algometer/dolorimeter in Total Shoulder Arthroplasty in 150 participants. Enrolling by invitation.
21 May 2026
Quick facts
| Lead sponsor | The Cooper Health System |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 21 May 2021 |
| Primary completion | 21 May 2026 |
| Estimated completion | 21 May 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pain Threshold using algometer/dolorimeter
Conditions studied
- Total Shoulder Arthroplasty — all drugs for Total Shoulder Arthroplasty →
- Postoperative Pain — all drugs for Postoperative Pain →
- Opioid Use — all drugs for Opioid Use →
Sponsor
The Cooper Health System — full company profile →
Who can join
18 and older, any sex, with Total Shoulder Arthroplasty or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this prospective research study is to evaluate the effects of preoperative pain threshold using a pressure algometer and its effects on postoperative patient satisfaction, return to work, and opioid consumption following Total Shoulder Arthroplasty (TSA). Participants will have their pain threshold measured at the preoperative visit. Postoperatively, they will be followed for 3 months and complete a pain journal for 2 weeks, record their medications consumed, and complete surveys at 2 weeks, 6 weeks, and 3 months. The study team will rely on the completion of the questionnaires, opioid consumption journal, and surveys to establish a correlation between pre-operative pain threshold and post-operative outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06133933
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Total Shoulder Arthroplasty
Currently open trials in the same condition.
- NCT06143306 — Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement · Phase 4 · recruiting
- NCT05900427 — Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients · Phase 4 · recruiting
Other The Cooper Health System trials
Trials by the same sponsor.
- NCT07296120 — RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · not yet recruiting
- NCT07042048 — Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization · NA · not yet recruiting
- NCT06462781 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1 · Phase 1 · completed
- NCT05974423 — Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair · Phase 4 · unknown
- NCT06398366 — Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06133933 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Cooper Health System
- Last refreshed: 20 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133933.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing